SS
Smita Samal
About Smita Samal
Data last updated:
Smita Samal is a Director at Medglobe Lifesciences Private Limited (since 2019), Director at Riozen Pharmaceutical Private Limited (since 2016) and Director at Mrk Facilities Private Limited (since 2024). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹3.20 Cr; the largest is Medglobe Lifesciences Private Limited at ₹3.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medglobe Lifesciences Private Limited U24230TG2019PTC137500 | Director | 11 Dec 2019 | 2019 | ₹3.19 Cr (FY 2025) | Active |
| Riozen Pharmaceutical Private Limited U74999AP2016PTC104381 | Director | 02 Nov 2016 | 2016 | ₹47,039 (FY 2024) | Active |
| Mrk Facilities Private Limited U74999OR2022PTC039828 | Director | 15 Jul 2024 | 2022 | Active |
Board colleagues of Smita Samal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajitesh Giri | 08008667 | Medglobe Lifesciences Private Limited | Director |
| Subarnalaxmi Sahoo | 08635475 | Medglobe Lifesciences Private Limited , Mrk Facilities Private Limited | Director |
| Jagdeep Bansal | 00698149 | Riozen Pharmaceutical Private Limited | Director |
| Kuldeep Bansal | 07623242 | Riozen Pharmaceutical Private Limited | Director |
| Rajesh Kumar Patra | 07623232 | Riozen Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Smita Samal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Smita Samal
Smita Samal currently holds 3 directorships: Medglobe Lifesciences Private Limited (Director, since 11 Dec 2019, revenue ₹3.19 Cr (FY 2025)); Riozen Pharmaceutical Private Limited (Director, since 02 Nov 2016, revenue ₹47,039 (FY 2024)); Mrk Facilities Private Limited (Director, since 15 Jul 2024).
Smita Samal was first appointed on 02 Nov 2016 as Director at Riozen Pharmaceutical Private Limited. The most recent appointment on record is 15 Jul 2024 at Mrk Facilities Private Limited.
The 2 current companies of Smita Samal that report revenue have a combined latest revenue of ₹3.20 Cr: Medglobe Lifesciences Private Limited ₹3.19 Cr (FY 2025); Riozen Pharmaceutical Private Limited ₹47,039 (FY 2024).
The current boards of Smita Samal's companies include Ajitesh Giri (Medglobe Lifesciences Private Limited), Subarnalaxmi Sahoo (Medglobe Lifesciences Private Limited), Jagdeep Bansal (Riozen Pharmaceutical Private Limited), Kuldeep Bansal (Riozen Pharmaceutical Private Limited), Rajesh Kumar Patra (Riozen Pharmaceutical Private Limited).